Skip to main content
HR 4565 114th Congress House Health Drug safety, medical device, and laboratory regulation Marketing and advertising Prescription drugs

Responsibility in Drug Advertising Act of 2016

Introduced: February 12, 2016 Introduced by: DeLauro, Rosa L. Democratic · Connecticut See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Feb 19, 2016
Referred to the Subcommittee on Health.
Feb 12, 2016
Referred to the House Committee on Energy and Commerce.
Feb 12, 2016
Introduced in House
 Plain-English summary Congressional Research Service

Responsibility in Drug Advertising Act of 2016

This bill amends the Federal Food, Drug, and Cosmetic Act to prohibit direct-to-consumer advertising of a drug in the first three years after the drug's approval. The Food and Drug Administration may: (1) waive the third year of this prohibition for a drug if direct-to-consumer advertising of the drug would have an affirmative value to public health, or (2) extend the prohibition if the drug has significant adverse health effects.
What's happening now February 19, 2016

Referred to the Subcommittee on Health.

 Committees of jurisdiction 2